Researchers at Abbott Pharmaceuticals have helped to solve this problem. The logic is simple. Synvisc is a natural elastoviscous substance which is injected into the knee's synovial space. In effect, Synvisc acts as a shock-absorber by adding its elasticity to the body's own fluid. But how quickly Synvisc works varies from patient to patient.
Some people notice a decrease in pain soon after the first injection.
So far, there have been no adverse systemic reactions to Synvisc. This is often due to improper injection and normally resolves in a few days. Synvisc is not a cure. But laboratory studies indicate its cushioning effect may help to protect cartilage cells. Nor is Synvisc an anti-inflammatory.